| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ken Ikeda, Junya Ebina, Kiyokazu Kawabe, Yasuo Iwasak. Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications. Internal medicine (Tokyo, Japan). vol 58. issue 12. 2019-09-24. PMID:30799370. |
parkinson disease (pd) is a slowly progressive neurodegenerative disease characterized by the loss of dopaminergic neurons and terminals in the nigrostriatal system. |
2019-09-24 |
2023-08-13 |
Not clear |
| Yoshikuni Tabata, Yoichi Imaizumi, Michiko Sugawara, Tomoko Andoh-Noda, Satoe Banno, MuhChyi Chai, Takefumi Sone, Kazuto Yamazaki, Masashi Ito, Kappei Tsukahara, Hideyuki Saya, Nobutaka Hattori, Jun Kohyama, Hideyuki Okan. T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease. Stem cell reports. vol 11. issue 5. 2019-09-20. PMID:30344006. |
t-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial parkinson disease. |
2019-09-20 |
2023-08-13 |
Not clear |
| Yoshikuni Tabata, Yoichi Imaizumi, Michiko Sugawara, Tomoko Andoh-Noda, Satoe Banno, MuhChyi Chai, Takefumi Sone, Kazuto Yamazaki, Masashi Ito, Kappei Tsukahara, Hideyuki Saya, Nobutaka Hattori, Jun Kohyama, Hideyuki Okan. T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease. Stem cell reports. vol 11. issue 5. 2019-09-20. PMID:30344006. |
parkinson disease (pd) is a progressive neurological disease caused by selective degeneration of dopaminergic (da) neurons in the substantia nigra. |
2019-09-20 |
2023-08-13 |
Not clear |
| Jeeyun Ahn, Jee-Young Lee, Tae Wan Kim, Eun Jin Yoon, Sohee Oh, Yu Kyeong Kim, Jong-Min Kim, Se Joon Woo, Ki Woong Kim, Beomseok Jeo. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease. Neurology. vol 91. issue 11. 2019-09-03. PMID:30111550. |
retinal thinning associates with nigral dopaminergic loss in de novo parkinson disease. |
2019-09-03 |
2023-08-13 |
Not clear |
| Jeeyun Ahn, Jee-Young Lee, Tae Wan Kim, Eun Jin Yoon, Sohee Oh, Yu Kyeong Kim, Jong-Min Kim, Se Joon Woo, Ki Woong Kim, Beomseok Jeo. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease. Neurology. vol 91. issue 11. 2019-09-03. PMID:30111550. |
to analyze the relationship between retinal thinning and nigral dopaminergic loss in de novo parkinson disease (pd). |
2019-09-03 |
2023-08-13 |
Not clear |
| Pascale Amberge. [Parkinson disease : how to improve the voice and the quality of life]. Revue medicale suisse. vol 15. issue 656. 2019-09-02. PMID:31268258. |
parkinson disease is a progressive neurodegenerative disease affecting the basal ganglia and causing the degeneration of dopaminergic neurons. |
2019-09-02 |
2023-08-13 |
Not clear |
| Matteo Dal Ben, Rosario Bongiovanni, Simone Tuniz, Emanuela Fioriti, Claudio Tiribelli, Rita Moretti, Silvia Gazzi. Earliest Mechanisms of Dopaminergic Neurons Sufferance in a Novel Slow Progressing Ex Vivo Model of Parkinson Disease in Rat Organotypic Cultures of Substantia Nigra. International journal of molecular sciences. vol 20. issue 9. 2019-08-20. PMID:31064126. |
earliest mechanisms of dopaminergic neurons sufferance in a novel slow progressing ex vivo model of parkinson disease in rat organotypic cultures of substantia nigra. |
2019-08-20 |
2023-08-13 |
human |
| Matteo Dal Ben, Rosario Bongiovanni, Simone Tuniz, Emanuela Fioriti, Claudio Tiribelli, Rita Moretti, Silvia Gazzi. Earliest Mechanisms of Dopaminergic Neurons Sufferance in a Novel Slow Progressing Ex Vivo Model of Parkinson Disease in Rat Organotypic Cultures of Substantia Nigra. International journal of molecular sciences. vol 20. issue 9. 2019-08-20. PMID:31064126. |
the current treatments of parkinson disease (pd) are ineffective mainly due to the poor understanding of the early events causing the decline of dopaminergic neurons (dopan). |
2019-08-20 |
2023-08-13 |
human |
| Shih-Yen Hsu, Hsin-Chieh Lin, Tai-Been Chen, Wei-Chang Du, Yun-Hsuan Hsu, Yi-Chen Wu, Po-Wei Tu, Yung-Hui Huang, Huei-Yung Che. Feasible Classified Models for Parkinson Disease from Sensors (Basel, Switzerland). vol 19. issue 7. 2019-08-09. PMID:30978990. |
feasible classified models for parkinson disease from the neuroimaging techniques such as dopaminergic imaging using single photon emission computed tomography (spect) with |
2019-08-09 |
2023-08-13 |
Not clear |
| Eldris Iglesias, Alba Pesini, Nuria Garrido-Pérez, Patricia Meade, M Pilar Bayona-Bafaluy, Julio Montoya, Eduardo Ruiz-Pesin. Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease. Ageing research reviews. vol 45. 2019-08-05. PMID:29689408. |
many inhibitors of this biochemical pathway, frequently found as persistent organic pollutants, affect dopaminergic neurogenesis, promote the degeneration of these neurons and increase the risk of suffering late-onset parkinson disease. |
2019-08-05 |
2023-08-13 |
Not clear |
| Simon Sung, Nirosen Vijiaratnam, Daniela Wan Chi Chan, Michael Farrell, Andrew H Evan. Parkinson disease: A systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation. Journal of the neurological sciences. vol 395. 2019-07-23. PMID:30401469. |
parkinson disease: a systemic review of pain sensitivities and its association with clinical pain and response to dopaminergic stimulation. |
2019-07-23 |
2023-08-13 |
Not clear |
| Wenming Li, Qian Yang, Zixu Ma. Signaling and induction of chaperone-mediated autophagy by the endoplasmic reticulum under stress conditions. Autophagy. vol 14. issue 6. 2019-06-28. PMID:29771174. |
this pathway is activated in response to stress associated with parkinson disease and is required for the viability of the snc dopaminergic neurons in an animal model of parkinson disease. |
2019-06-28 |
2023-08-13 |
Not clear |
| Jason A Whitfield, Angela Reif, Alexander M Goberma. Voicing contrast of stop consonant production in the speech of individuals with Parkinson disease ON and OFF dopaminergic medication. Clinical linguistics & phonetics. vol 32. issue 7. 2019-06-26. PMID:29064294. |
voicing contrast of stop consonant production in the speech of individuals with parkinson disease on and off dopaminergic medication. |
2019-06-26 |
2023-08-13 |
Not clear |
| Jason A Whitfield, Angela Reif, Alexander M Goberma. Voicing contrast of stop consonant production in the speech of individuals with Parkinson disease ON and OFF dopaminergic medication. Clinical linguistics & phonetics. vol 32. issue 7. 2019-06-26. PMID:29064294. |
the aims of this study were to: 1) compare voicing contrast in speakers with parkinson disease (pd) and healthy controls by comparing the separation of voice onset time (vot) distributions of voiced and voiceless stop consonants and 2) to determine whether the administration of dopaminergic medication affected vot separation in speakers with pd. |
2019-06-26 |
2023-08-13 |
Not clear |
| Paul Crawford, Ethan E Zimmerma. Tremor: Sorting Through the Differential Diagnosis. American family physician. vol 97. issue 3. 2019-05-28. PMID:29431985. |
if there is diagnostic uncertainty, single-photon emission computed tomography can be used to visualize the integrity of the dopaminergic pathways in the brain, and transcranial ultrasonography may be useful to diagnose parkinson disease. |
2019-05-28 |
2023-08-13 |
Not clear |
| Eduard Tolosa, Teresa Botta-Orfila, Xavier Morató, Carles Calatayud, Raquel Ferrer-Lorente, María-José Martí, Manel Fernández, Carles Gaig, Ángel Raya, Antonella Consiglio, Mario Ezquerra, Rubén Fernández-Santiag. MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients. Neurobiology of aging. vol 69. 2019-05-21. PMID:29935433. |
microrna alterations in ipsc-derived dopaminergic neurons from parkinson disease patients. |
2019-05-21 |
2023-08-13 |
Not clear |
| Sarah A McClymont, Paul W Hook, Alexandra I Soto, Xylena Reed, William D Law, Samuel J Kerans, Eric L Waite, Nicole J Briceno, Joey F Thole, Michael G Heckman, Nancy N Diehl, Zbigniew K Wszolek, Cedric D Moore, Heng Zhu, Jennifer A Akiyama, Diane E Dickel, Axel Visel, Len A Pennacchio, Owen A Ross, Michael A Beer, Andrew S McCallio. Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons. American journal of human genetics. vol 103. issue 6. 2019-05-14. PMID:30503521. |
the progressive loss of midbrain (mb) dopaminergic (da) neurons defines the motor features of parkinson disease (pd), and modulation of risk by common variants in pd has been well established through genome-wide association studies (gwass). |
2019-05-14 |
2023-08-13 |
mouse |
| Dilini Rathnayake, Thashi Chang, Preethi Udagam. Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study. BMC neurology. vol 19. issue 1. 2019-05-14. PMID:30954070. |
dopaminergic neuronal loss begins years before motor symptoms appear in parkinson disease (pd). |
2019-05-14 |
2023-08-13 |
Not clear |
| Katriana A Popichak, Sean L Hammond, Julie A Moreno, Maryam F Afzali, Donald S Backos, Richard D Slayden, Stephen Safe, Ronald B Tjalken. Compensatory Expression of Nur77 and Nurr1 Regulates NF- Molecular pharmacology. vol 94. issue 4. 2019-04-16. PMID:30111648. |
compensatory expression of nur77 and nurr1 regulates nf- inflammatory activation of glial cells promotes loss of dopaminergic neurons in parkinson disease. |
2019-04-16 |
2023-08-13 |
Not clear |
| Doo Chul Choi, Myungsik Yoo, Savan Kabaria, Eunsung Jun. MicroRNA-7 facilitates the degradation of alpha-synuclein and its aggregates by promoting autophagy. Neuroscience letters. vol 678. 2019-04-15. PMID:29738845. |
alpha-synuclein (α-syn) is an important protein in the pathogenesis of parkinson disease (pd) as it accumulates as fibrillar inclusions in affected brain regions including dopaminergic neurons in the substantia nigra. |
2019-04-15 |
2023-08-13 |
Not clear |